Your browser doesn't support javascript.
loading
Cerebrospinal fluid peptides as potential Parkinson disease biomarkers: a staged pipeline for discovery and validation.
Shi, Min; Movius, James; Dator, Romel; Aro, Patrick; Zhao, Yanchun; Pan, Catherine; Lin, Xiangmin; Bammler, Theo K; Stewart, Tessandra; Zabetian, Cyrus P; Peskind, Elaine R; Hu, Shu-Ching; Quinn, Joseph F; Galasko, Douglas R; Zhang, Jing.
Afiliación
  • Shi M; From the ‡Department of Pathology, University of Washington School of Medicine, Seattle, Washington 98104;
  • Movius J; From the ‡Department of Pathology, University of Washington School of Medicine, Seattle, Washington 98104;
  • Dator R; From the ‡Department of Pathology, University of Washington School of Medicine, Seattle, Washington 98104;
  • Aro P; From the ‡Department of Pathology, University of Washington School of Medicine, Seattle, Washington 98104;
  • Zhao Y; From the ‡Department of Pathology, University of Washington School of Medicine, Seattle, Washington 98104;
  • Pan C; From the ‡Department of Pathology, University of Washington School of Medicine, Seattle, Washington 98104;
  • Lin X; From the ‡Department of Pathology, University of Washington School of Medicine, Seattle, Washington 98104; §School of Life Sciences, Fujian Agriculture and Forestry University, Fuzhou, Fujian 350002, China;
  • Bammler TK; ¶Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, Washington 98195;
  • Stewart T; From the ‡Department of Pathology, University of Washington School of Medicine, Seattle, Washington 98104;
  • Zabetian CP; ‖Geriatric and Parkinson's Disease Research, Education, and Clinical Centers, Veterans Affairs Puget Sound Health Care System, Seattle, Washington 98108; **Department of Neurology, University of Washington School of Medicine, Seattle, Washington 98195;
  • Peskind ER; ‡‡Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle, Washington 98195; §§Mental Illness Research, Education, and Clinical Center, Veterans Affairs Puget Sound Health Care System, Seattle, Washington 98108;
  • Hu SC; ‖Geriatric and Parkinson's Disease Research, Education, and Clinical Centers, Veterans Affairs Puget Sound Health Care System, Seattle, Washington 98108; **Department of Neurology, University of Washington School of Medicine, Seattle, Washington 98195;
  • Quinn JF; ¶¶Department of Neurology, Oregon Health and Science University, Portland, Oregon 97239;
  • Galasko DR; ‖‖Department of Neurosciences, University of California at San Diego, La Jolla, California 92093.
  • Zhang J; From the ‡Department of Pathology, University of Washington School of Medicine, Seattle, Washington 98104; zhangj@u.washington.edu.
Mol Cell Proteomics ; 14(3): 544-55, 2015 Mar.
Article en En | MEDLINE | ID: mdl-25556233
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedad de Parkinson / Péptidos / Espectrometría de Masas / Biomarcadores / Proteómica / Enfermedad de Alzheimer Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Mol Cell Proteomics Asunto de la revista: BIOLOGIA MOLECULAR / BIOQUIMICA Año: 2015 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedad de Parkinson / Péptidos / Espectrometría de Masas / Biomarcadores / Proteómica / Enfermedad de Alzheimer Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Mol Cell Proteomics Asunto de la revista: BIOLOGIA MOLECULAR / BIOQUIMICA Año: 2015 Tipo del documento: Article